Retrospective study of blood culture isolates, antimicrobial sensitivity, and survival factors from 243 neonatal foals in Normandy (France) Authors: Marion Vigneau, Valérie Picandet, Florence Polle, Virginie Guérin, Sandrine Petry, Loic Desquilbet, Emilie Quéré Published: 2026 ABSTRACT AbstractBackgroundIdentifying causative bacterial species in neonatal foal bacteremia and their antimicrobial susceptibility profiles is essential for guiding appropriate antibiotic therapy.Hypothesis/ObjectivesTo describe bacterial isolates from blood culture and their antimicrobial susceptibility patterns in neonatal foals from two French institutes, and to assess associations between pretreatment and blood culture positivity, and between in-hospital death (euthanasia or natural death) and the presence of multidrug-resistant (MDR) bacteria.AnimalsTwo hundred forty-three foals (<7 days old) admitted to two equine intensive care units in Normandy with blood cultures.MethodsRetrospective cohort study. Associations were assessed using chi-square test.ResultsBlood cultures were positive in 43% of foals. Pretreatment was not significantly associated with blood culture positivity (P = .62). Gram-positive isolates predominated (65%). The most common isolates were Staphylococcus spp. (25%), Escherichia coli (11%), and Streptococcus spp. (11%). MDR bacteria represented 26% of isolates, predominantly Gram-positive. Low resistance to aminoglycosides, particularly amikacin (17%) and gentamicin (19%), was observed, whereas resistance to penicillin (53%) and ceftiofur (33%) was more common. Moderate resistance to tetracyclines (between 22% and 31%) was measured within overall bacteria. Similar resistance rates to trimethoprim–sulfamethoxazole and ceftiofur were observed among Gram-positive (≈ 35%) and Gram-negative isolates (26%). Presence (vs absence) of MDR isolates was not significantly associated with in-hospital death (P = .52).Conclusions and clinical importanceConsistent with recent reports, Gram-positive bacteria predominated among neonatal foal blood isolates in our sample. Despite its designation as a critically important human antibiotic, resistance to ceftiofur in our study necessitates utmost restraint in its use. Introduction Despite medical care advancements, sepsis remains a major cause of morbidity and death in neonatal foals, particularly in those under 7 days of age.1-3 Obtaining a definitive diagnosis of sepsis is challenging, as it is primarily characterized by a clinical syndrome rather than by a specific set of diagnostic tests.4 Bacteremia can be diagnosed using a blood culture; however, this diagnostic method also presents several limitations, including the time needed to obtain results (up to 7 days) and moderate sensitivity and specificity.2,5,6 Because sepsis is a life-threatening emergency, prompt and aggressive empirical antimicrobial therapy is necessary while awaiting the culture results, and this early action has been associated with a positive outcome.1,7 In human medicine, the actual guidelines recommend the administration of antimicrobials within 1 hour of recognition for children and adults with possible septic shock or a high likelihood for sepsis, and within 3 hours for children and adults with possible sepsis without shock, to mitigate morbidity and mortality.8,9 Some authors propose that previous administration of antimicrobials could reduce the positivity of blood cultures, based on studies conducted in humans.2,10,11 To the authors’ knowledge, this finding has not been confirmed in equine neonatal medicine. Clinicians must be aware of potential pathogens and their antimicrobial susceptibility patterns in bacteremic foals to ensure appropriate empirical treatment and to improve hospital outcomes.1,12,13 Until 2015, Gram-negative bacteria were more frequently isolated from blood cultures of septicemic newborn foals in Europe, the USA, and Australia,1,12-17 although a trend toward an increase in the proportion of Gram-positive bacteria was detected.1 This reversal in the trend has now been confirmed by numerous studies conducted on all of the aforementioned continents, with a majority of Gram-positive bacteria identified in cultures collected from newborn foals.2,6,18,19 The growing problem of antimicrobial resistance in both human and veterinary medicine further complicates empirical therapy, especially as Gram-positive bacteria have unpredictable sensitivity patterns.13 In studies conducted in human patients with sepsis, higher case fatality rates are detected among patients with multidrug-resistant (MDR) bacteria (vs non-MDR), and isolation of MDR bacteria is an independent predictor for death.20,21 On the contrary, several equine studies do not find any significant association between a foal’s survival and the presence of MDR isolates.2,6,18 The main objective of this multicenter study was to document the bacterial culture and antimicrobial susceptibility results of critically ill neonatal foals admitted to two equine hospitals in Normandy, France, in order to update the data for this breeding region. The second objective of the study was to investigate the association between foal death during hospitalization and the detection of MDR bacteria. We hypothesized that blood culture results would reveal a predominance of Gram-positive infections and increased antimicrobial resistance compared to previous studies. We also hypothesized that the presence of MDR bacteria in blood cultures of newborn foals would be associated with a higher case fatality rate, as has been suggested in human patients. Altogether, the results could provide valuable information to veterinarians, aiding in the selection of empirical antibiotic therapy for neonatal foals with sepsis. Materials and methods Case selection Case records of foals < 7 days old at the time of admission to the intensive care unit (ICU) of two equine clinics in Normandy were reviewed between 2021 and 2024 for clinic A (Livarot, France) and between 2022 and 2024 for clinic B (Écouché-les-Vallées, France). All foals < 7 days old with a blood culture obtained immediately or within 5 days upon admission were included in the study. Age, sex, breed, clinical pathology and bacteriology results, antimicrobial therapy before referral and critically important antimicrobials (CIAs) administration before or during hospitalization, and outcome were recorded for each foal. Survival was defined as live discharge from the clinic. Bacterial culture and antibiotic susceptibility tests Blood samples were aseptically collected from the jugular vein of foals or through jugular catheters at the time of placement. Blood cultures were performed using broth inoculation (Oxoid, Signal, Thermo Fisher Scientific) for clinic A or using the lysis–centrifugation method with resins for antimicrobial neutralization (combination of BD BACTEC Plus aerobic and lytic anaerobic media) for clinic B. If a sample yielded bacteria within 5 days of culture, pathogens were identified by matrix-assisted laser desorption/ionization-time of flight mass spectrometry technology (MALDI-TOF, BioMérieux) for clinic A and by Vitek bacterial identification system (BioMérieux) for clinic B after subculturing in different culture media (nonselective agar, MacConkey agar for Gram-negative bacteria, ANC agar for Gram-positive bacteria and Schaedler agar for anaerobic bacteria). Finally, an antibiotic susceptibility test (AST) was performed using the disk diffusion method with a SIRSCAN Orion (i2a) for clinic A and SIRSCAN Lynx (i2a) for clinic B. Antimicrobials were tested based on the bacteria identified, in accordance with current conventional microbiological methods in France (CA-SFM 2021/EUCAST),22 and based on the availability of molecules for veterinary medicine (for clinic A). The antimicrobials that were being tested were: penicillin G, amoxicillin, ampicillin, amoxicillin–clavulanic acid, and ceftiofur for β-lactams; gentamicin, amikacin, and streptomycin for aminoglycosides; enrofloxacin and marbofloxacin for fluoroquinolones; tetracycline, doxycycline, oxytetracycline, and chlortetracycline for tetracyclines; erythromycin, tulathromycin, and azithromycin for macrolides; trimethoprim–sulfamethoxazole (TMPS); chloramphenicol; and rifampicin. For financial reasons, AST was not performed for foals that died before results became available. All bacteria isolated from a single sample were identified and recorded. An isolate with a resistant or intermediate result on AST was considered as resistant for the antimicrobial treatment(s) of interest. MDR bacteria were defined as isolates resistant to three or more antimicrobial classes.23 An antimicrobial was theoretically effective against a bacteria if it elicited < 30% resistance in vitro.2,19 Data analysis Bacterial prevalence and resistance patterns were summarized as counts and proportions. Exact 95% confidence intervals were calculated using the Clopper-Pearson method.24 When supported by previous literature, associations were assessed using the χ-square test. The rates of positive blood cultures were compared between foals that received antimicrobials before blood culture collection (pretreatment) and those that did not. The association between in-hospital death (either euthanasia or natural death) and the presence (vs absence) of MDR isolates was assessed in foals with positive blood cultures. Data analysis was performed using SAS Software (SAS Studio 3.8, SAS Institute Inc.). Statistical significance was set at P ≤ .05. Results Study sample In total, 243 foals were included in the study. Of these, 104 returned positive blood cultures (43%), from which 142 microorganisms were isolated, including 139 bacteria, 1 yeast, and 2 unidentified pathogens. In total, 127 ASTs were performed (Figure 1). Bacterial isolation yielded 2 species in 24 foals (23%), 3 species in 4 foals (4%), and 4 species in 2 foals (2%). Flow chart of the case selection process for blood culture samples and associated. Prevalence of bacterial isolates and antimicrobial susceptibility Gram-positive bacteria accounted for 65% isolates. The most predominant bacterial species isolated were Staphylococcus spp. (36/142; 25%), Escherichia coli (16/142; 11%) and others Enterobacteriaceae (9/142; 6%), Streptococcus spp. (16/142; 11%), Enterococcus spp. (10/142; 7%), Moraxella spp. (11/142; 7%) and Pasteurella spp. (7/142; 5%) (Table 1). Half of the Streptococcus spp. were α-hemolytic, while the remaining half were β-hemolytic. Only 2 anaerobes were isolated (Clostridium spp.). Table 1Prevalence of bacterial species isolated from blood of neonatal foals admitted to the intensive care unit.Identification of isolatesGlobal positive sample (n = 142) Gram-positive, n (%) 92 (65%) Staphylococcus spp.36 (25%) Streptococcus spp.16 (11%) Enterococcus spp.10 (7%) Weissella spp.6 (6%) Bacillus spp.5 (4%) Corynebacterium spp.3 (3%) Clostridium spp.2 (1%)Other Gram-positive14 (10%) Gram-negative, n (%) 47 (33%) Enterobacteriaceae 25 (17%) Escherichia coli 16 (11%) Moraxella spp.11 (7%) Pasteurella spp.7 (5%)Other Gram-negative4 (3%) Yeast 1 (<1%) Nonidentifiable pathogens 2 (1%) Prevalence of bacterial species isolated from blood of neonatal foals admitted to the intensive care unit. Among the 127 ASTs performed, 26% (33/127) identified MDR bacteria, most of which were Gram-positive (70%), such as Weissella spp., Enterococcus spp., Staphylococcus spp., and Streptococcus spp. (Annex 1). Four foals had several MDR bacteria in their blood cultures. Annex 1Prevalence of multidrug-resistant bacteria isolated from neonatal foals admitted to intensive care unit with a blood culture. MDR bacteria Prevalence (n = 33) Gram-positive 23 (70%) Weissella spp.6 (18%) Enterococcus spp.5 (15%) Staphylococcus spp.4 (12%) Streptococcus spp.3 (9%) Corynebacterium spp.1 (3%) Bacillus spp.1 (3%) Lactobacillus spp.1 (3%) Aerococcus spp.1 (3%)Unidentified Gram-positive1 (3%) Gram-negative 10 (30%) Acinetobacter spp.4 (12%) Pseudomonas spp.2 (6%) Escherichia coli 1 (3%) Pantoea spp.1 (3%) Kluyvera spp.1 (3%) Stenotrophomonas spp.1 (3%)MDR: multidrug-resistant. Prevalence of multidrug-resistant bacteria isolated from neonatal foals admitted to intensive care unit with a blood culture. MDR: multidrug-resistant. The antimicrobial resistance patterns of all isolated bacteria are presented in Table 2, according to their AMEG (Agreed by the Antimicrobial Advice ad hoc Expert Group) categorization25 updated in 2025, from the European Medicines Agency (EMA). Levels of resistance among overall bacterial isolates with an upper confidence interval limit below 30% were observed for aminoglycosides (gentamicin 19% [95% CI, 12-26], amikacin 17% [95% CI, 11-25], streptomycin 20% [95% CI, 13-28%]), fluoroquinolones (marbofloxacin 17% [95% CI, 11-24], enrofloxacin 19% [95% CI, 13-27]), and macrolides (erythromycin 18% [95% CI, 10-28]). Gram-negative bacteria presented a level of resistance to TMPS with an average below 30% but a confidence interval above that level (26% [95% CI, 14-42]), as was the case for ceftiofur (26% [95% CI 12-45]) and for most tetracyclines within the overall bacterial population (tetracycline 25% [95% CI 17-33], oxytetracycline 22% [95% CI, 13-33], chlortetracycline 22% [95% CI, 12-35]). Table 2Antimicrobial susceptibility patterns of isolates from foals admitted to intensive care unit, with the number and percentage of isolates resistant to antimicrobials, and the associated 95% CIs. Results are presented according to the EMA antibiotic categorization.25 In parenthesis: number of resistant bacteria/number of bacteria tested.In bold: upper limit of the 95 CI ≤ 30%, efficacy threshold.Gray: Category D “Prudence”, should be used as first line treatments, whenever possibleYellow: Category C “Caution”, should be considered only when there are no antibiotics in Category D that could be clinically effective.Orange: Category B “Restrict”, use should be based on antimicrobial susceptibility testing, wherever possible (also known as critically important antimicrobials).Red: Category A “Avoid”, antibiotics in this category are not authorized as veterinary medicines in the EU. Antimicrobial susceptibility patterns of isolates from foals admitted to intensive care unit, with the number and percentage of isolates resistant to antimicrobials, and the associated 95% CIs. Results are presented according to the EMA antibiotic categorization.25 In parenthesis: number of resistant bacteria/number of bacteria tested. In bold: upper limit of the 95 CI ≤ 30%, efficacy threshold. Gray: Category D “Prudence”, should be used as first line treatments, whenever possible Yellow: Category C “Caution”, should be considered only when there are no antibiotics in Category D that could be clinically effective. Orange: Category B “Restrict”, use should be based on antimicrobial susceptibility testing, wherever possible (also known as critically important antimicrobials). Red: Category A “Avoid”, antibiotics in this category are not authorized as veterinary medicines in the EU. Antimicrobial administration before referral Forty-three foals received antimicrobial treatment at the stable before transfer to the ICU and before blood culture collection (pretreatment). The antimicrobial most commonly administered before referral was ceftiofur (21/43; 49%), followed by TMPS (7/43; 16%) and the combination of penicillin/gentamicin (5/43; 12%). Among foals treated with ceftiofur at the stable, 14% (4/21) were subsequently found to be carriers of bacteria resistant to this antimicrobial in their blood culture samples. Similarly, among foals treated with TMPS, 29% (2/7) were subsequently found to be carriers of bacteria resistant to this antimicrobial in their blood culture samples, and among foals treated with penicillin/gentamicin, 40% (3/5) were found to carry penicillin-resistant bacteria. The proportions of positive blood cultures between pretreated (40%; 17/43) and nonpretreated foals (44%; 87/199) were not significantly different (P = .62). Infection characteristics and in-hospital case fatality rate A total of 44/243 foals (18%) died during hospitalization. The case fatality rates were 22% (23/104) and 15% (21/139) in foals with positive and negative blood cultures, respectively. Among the 104 foals with positive blood cultures, the case fatality rates were 18% (5/25) and 24% (18/76; P = .52), respectively, for the presence and absence of MDR isolates. Discussion This study describes blood culture results in neonatal foals admitted to ICUs in Normandy, France, between 2021 and 2024 for one clinic and between 2022 and 2024 for another. Our results were generally consistent with previous published studies, particularly, pertaining to the percentage of positive blood cultures, most common species isolated (showing a predominance of Gram-positive bacteria), occurrence of mixed infections, increasing ceftiofur resistance, and observed case fatality rate. However, the prevalence of E. coli, anaerobic bacteria, and MDR bacteria in our study sample varied from previous findings. Prevalence of bacterial isolates In the present study, 43% of blood cultures were positive, which is at the high end of previously reported rates of between 28.5% and 42.5%.10,16,26 This wide range of rates across studies likely reflects differences in bacterial culture techniques or preanalytical factors that influence blood culture sensitivity, such as blood volume, number of samples, sampling site, puncture site preparation, use of sterile gloves, antiseptic protocol, and collection method (eg, catheter vs direct collection).10 To date, no standardized blood sampling techniques have been established in either human or veterinary medicine.27 While earlier studies conducted between 1994 and the 2010s reported percentages of isolated Gram-negative bacteria ranging from 54.5% to 75%,1,13,14,16,28,29 more recent studies have reported higher percentages of isolated Gram-positive bacteria at between 56% and 75%.2,6,18,30,31 This pattern was also observed in our study (65% Gram-positive bacteria). Staphylococcus spp. was the most frequently isolated bacterial genus (25%), with 13 different species identified, followed by Enterobacteriaceae (17%), with E. coli as the predominant species (11%). The prevalence of E. coli in our study was lower than reported rates of 16%-33%.1,2,6,13,16,28-30,32 This discrepancy might reflect temporal and geographical variations in bacterial prevalence and species distribution.1,19 Finally, multiple bacterial species were detected in 29% of foals with positive blood cultures, which is consistent with the literature, reporting mixed infections accounting for 14.9%-52.6% of cases.1,16,28,31 However, such samples revealing three or more isolates might have possibly been contaminated. A recent human study has suggested that time to positivity of blood cultures could be a useful tool to distinguish contamination from true bacteremia, especially in cases involving coagulase-negative staphylococci. Although our retrospective study did not include time-to-positivity data, such information could be of interest for microbiology laboratories to improve interpretation of positive blood cultures in equine neonates.33 Antimicrobial resistance With the increasing incidence of antimicrobial resistance, bacteriological sampling and susceptibility testing become ever more crucial for guiding appropriate antimicrobial therapy. In our study, MDR isolates accounted for 26% of cases, which is a lower rate than that reported in Australia between 2005 and 2022 (44%) and in Ontario, Canada between 2020 and 2023 (78%) but higher than that reported in a recent UK study (21%).2,18,19 This discrepancy might indicate differences in routine antimicrobial treatment practices between countries. In our study, bacterial isolates exhibited the lowest resistance rates to aminoglycosides, particularly amikacin, for which only 17% [95% CI, 11-25] of all isolates were classified as resistant, and 12% [95% CI, 4-26] of Gram-negative isolates. Regarding gentamicin, 26% [95% CI, 14-41] of Gram-negative isolates were resistant to this antimicrobial in our study, with an overall resistance rate of 19% [95% CI, 12-26]. These results contrast with a recent Canadian study that collected all bacterial cultures from foals < 30 days old, in which gentamicin sensitivity was very low (39% sensitivity, meaning 61% resistance).19 According to the 2024 Resapath annual report on AST data from diseased animals in France,34 bacterial resistance of E. coli to amikacin remains low and stable in France. Aminoglycosides belong to the AMEG category C “Caution”, which means that they should only be considered if category D antibiotics that would be clinically effective are unavailable.25 Fluoroquinolones were also associated with relatively low resistance rates among bacterial isolates in vitro, but can induce severe cartilage erosions and synovitis in young foals.35 Moreover, fluoroquinolones belong to AMEG category B “Restrict”, also known as CIA, which means that they should only be considered when there are no antimicrobials in categories C or D that could be clinically effective, and their use should be based on antimicrobial susceptibility testing (AST), wherever possible.25 Tetracyclines (eg, tetracycline, oxytetracycline, and doxycycline) were associated with moderate resistance rates (with an average below 30% but an upper limit of the 95% CI above this value). This antimicrobial class appears to be an interesting option as they exhibit favorable susceptibility profiles, and belong to AMEG category D (first-line treatments).25 However, their use varies depending on regional practices. Due to their bacteriostatic nature, they are rarely used in France to treat neonatal sepsis, but they can be useful in treating minor bacterial infections with an oral formulation, particularly umbilical abscesses instead of TMPS.36,37 They can also have adverse effects, such as altered bone development, as well as yellowing of permanent teeth in young individuals.35,36,38 In our study, Gram-positive and Gram-negative bacteria exhibited moderate to high levels of resistance to TMPS, with 35% [95% CI, 25-47] and 26% [95% CI, 14-42] resistance, respectively, exhibiting a similar profile as that of ceftiofur (36% [95% CI, 25-48] and 26% [95% CI, 12-45], respectively). Unlike ceftiofur, TMPS has the advantage of being classified into AMEG category D (first-line treatments)25 and can be administered in foals at 24 mg/kg PO or intravenously every 12 hours.37 The resistance percentages to ceftiofur exhibiedt in this study were similar to those observed in a recent Canadian study (34% and 29%, respectively); however, resistance against TMPS was higher (52% and 48%, respectively).19 According to the 2024 Resapath report,34 E. coli resistance to ceftiofur is decreasing in most animal species, except for horses. Concurrently, Flood et al. (2025)2 also reported reduced sensitivity to ceftiofur in their study. Therefore, ceftiofur might not be suitable as a first-line treatment option, beyond the regulatory aspect of the AMEG categorization (category B).25 According to ASTs, penicillin was associated with a high resistance rate of 51% [95% CI, 40-62] among Gram-positive isolates, and amoxicillin–clavulanic acid with a moderate resistance rate of 26% [95% CI, 17-37] among Gram-positive bacteria. When comparing resistance rates within the β-lactam antimicrobial class, amoxicillin–clavulanic acid appears to be a more appropriate option than penicillin, amoxicillin, or ampicillin. However, amoxicillin–clavulanic acid belongs to the AMEG category C.25 Practical choice of an antimicrobial in France Considering European legislation and the resistance profiles identified in our study, tetracyclines and TMPS, belonging to the AMEG category D,25 appear to be reasonable first-line treatment options, with oral and IV formulations available, at least in France. The use of tetracyclines in newborn foals must be carefully considered, taking into account their specific characteristics. The resistance rates for TMPS were relatively high in our study, but they were comparable to those observed for ceftiofur. As a second option and belonging to the AMEG category C,25 aminoglycosides appear to be an appropriate alternative for the treatment of Gram-negative bacterial infections and staphylococcal infections, with low resistance percentages. Gentamicin and streptomycin are licensed for veterinary use in France, contrary to amikacin. To broaden their spectrum of activity, aminoglycosides could be combined with β-lactam antimicrobials, with which they exhibit synergistic bactericidal activity.32 The combination of penicillin-gentamicin is often used in foals for the treatment of neonatal sepsis and streptococcal or enterococcal infections,36,39 and was administered as field-initiated treatment to 12% (5/43) of the nonpretreated foals in our study. It would have been interesting to measure the combined action of those antimicrobials in ASTs, as was it done in the study of Seoane et al.19 Amoxicillin-clavulanic acid appears interesting based on our results, with moderate resistance levels among Gram-positive bacteria, but its use in foals is restricted to oral administration (30 mg/kg bwt, q. 6-8 h) due to rapid elimination of amoxicillin in serum following IV administration.39-41 Parenteral administration is preferable for severely ill septic foals.8,39,42 This is why ceftiofur is often the first-line treatment used in field conditions, when IV access is not available, thanks to its ability to be administered IM and its favorable renal safety profile. This combination could therefore be used for less severe foals that can be treated with oral antimicrobials or for foals with bacterial resistance to AMEG category D antibiotics.25 Administration of antimicrobials before blood culture The literature is inconsistent regarding the administration of antimicrobials before blood culture. A large study conducted in adult human patients11 showed that the rate of positive blood cultures from a single sample decreases by more than 50% between 2 and 72 h after initiation of IV antimicrobials. These findings were subsequently applied to veterinary medicine, and some studies have suggested that antimicrobial pretreatment could reduce the rate of positive blood cultures.2,27 However, a study involving 50 foals did not find any significant relationship between the administration of antimicrobials before blood culture sampling and negative blood culture results.23 Similarly, our study involving 104 foals with positive blood cultures did not provide evidence of such an association between antimicrobial pretreatment and rate of positive blood cultures. The current recommendations of the human medicine community advocate for blood sampling before the administration of antibiotics, which should be performed within a time frame of 1 to 3 hours after the diagnosis of sepsis, contingent on the condition severity.8,9 MDR isolates and in-hospital case fatality rate Although MDR bacterial infections have been associated with an increased risk of death in human patients,20,21 the in-hospital case fatality rate in the present study (18%) did not differ significantly between foals with and without MDR infections. Similarly, previous equine studies do not report a significant association between MDR status and death.2,6,18 Limitations This study presents several limitations. It would have been useful to compare subgroups of foals based on clinical presentation, such as healthy foals, sick non-septic foals, and septic foals, rather than exclusively on blood culture results. Regarding bacterial isolation, the concurrent detection of four bacterial species in the same sample might indicate contamination rather than polymicrobial infection, given the low probability that all four bacterial species are truly pathogenic. The choice of antimicrobials tested for ASTs was based on the current French conventional microbiological methods22 and on the availability of systemic drugs in veterinary medicine in France. Consequently, some antimicrobials, as chloramphenicol, were rarely tested due to infrequent use, meaning the percentage of resistant isolates was sometimes based on a small sample size. Exact 95% CIs highlight this limitation when interpreting the results for some antimicrobials. Furthermore, our results might restrict extrapolation to other European countries or beyond, due to varying legislation regarding the use of antibiotics in horses. In addition, despite their frequent use in clinical practice, combinations of antimicrobial treatments were not assessed for their potential synergistic effects, which could have provided valuable additional insights. While the retrospective study design resulted in relatively minor data loss, the multicenter nature of the study resulted in data heterogeneity. Although the two clinics were geographically close, they differed in terms of stable populations, therapeutic practices, and bacteriological analytical methods. These differences, particularly in population size and laboratory methods, limit the comparability and interpretation of data between the two clinics. Finally, some foals might have been euthanized for financial reasons; as the reasons for euthanizing foals were not documented in the clinical records. Nevertheless, the number of such euthanasia cases is likely low because the two clinics mainly serve professional and well-informed breeders. Therefore, the foals admitted to intensive care were presumably those for which the breeder was willing to spend a significant amount of money. Conclusion This study reports the results of a preliminary analysis of blood cultures of foals with bacteremia in Normandy, an important breeding region in France. Our results showed a high prevalence of Gram-positive bacteria, with a majority of Staphylococcus spp., in blood cultures from 243 neonatal foals < 7 days old that were admitted to two clinics in France between 2021 and 2024 for one clinic and between 2022 and 2024 for the other. This finding was consistent with recent reports from many countries. The proportion of MDR bacteria was lower than those recently reported in Australian and Canadian studies2,19 but higher than in a recent UK study.18 Our results did not provide evidence that multidrug resistance (MDR vs non-MDR infections) is associated with greater in-hospital foal death. However, they should not be interpreted as evidence that no association exists.43 Low levels of resistance were observed for aminoglycosides and fluoroquinolones among all bacteria. Resistance rates for TMPS were similar to those observed for ceftiofur in our study. All these considerations underscore the importance of promptly performing bacterial cultures and AST, enabling the timely adaptation of treatments.